Abstract
Introduction
In spite of recent advances in CHF treatment, CHF remains a major cause of morbidity and mortality worldwide, and one of the leading medical causes of hospitalization among people aged greater than 60 years [1] . Previous studies in Western CHF populations have shown a racial disparity in clinical outcome, with Blacks having a worse survival compared to Caucasians [2] . There is a paucity of data in the literature regarding the influence of race on clinical outcome in an Asian CHF population. The aim of this prospective study is to evaluate whether race has an impact on clinical outcome in patients with CHF in the multiracial population of Singapore.
Materials and methods

Study population
668 consecutive CHF patients (recruited from Tan Tock Seng Hospital and National University Hospital) were enrolled into the National Healthcare Group Multidisciplinary Heart Failure Disease Management Program from October 2002 to September 2004. Classification into the different races was done by patient self-report. The racial groups consisted of Chinese (481, 72%), Malays (114, 17.1%), and Indians (73, 10.9%). The inclusion and exclusion criteria have previously been described [3] .
Study design
In this prospective observational study, baseline demographics and clinical characteristics including information on medications, New York Heart Association class (NYHA) and 6-minute walk test distance were recorded. Information on the number of hospitalizations and deaths were collected prospectively. Patients were followed up at one to six monthly intervals. The cardiac medications were uptitrated accordingly until maximal tolerated doses. This study was approved by the hospital ethics committee.
Statistical analysis
Continuous variables in text and tables are expressed as mean ± standard deviation and compared by KruskalWallis test. Chi-square test was used to test associations between categorical variables. Logistic regression was applied to identify independent predictors of the composite end-point. The final multivariate model for predicting the composite end-point was selected by backward elimination, beginning with inclusion of all significant variables identified on univariate analysis. Some of the significant covariates were omitted from the final model due to multicollinearity. All statistical tests were conducted at 5% level of significance.
Results
Follow-up was complete for all study patients (Age 66 ± 12 years, Ejection fraction 29 ± 13%). At end of study (24 ± 12 months), 198 patients (29.6%) reached the composite end-point (133 deaths, 112 CHF readmissions).
DM (61% vs 54% vs 45%), peripheral vascular disease (8.5% vs 0.9% vs 3.6%,) and hyperlipidemia (70% vs 53% vs 55%) were more prevalent in Indians compared to Malays or Chinese (all p b 0.05). A trend towards greater prevalence of ischemic cardiomyopathy was seen in Indians, compared to Malays or Chinese (78% vs 69% vs 67%, p = 0.18). Left ventricular ejection fraction, 6-minute walk test distance, NYHA class and use of ACEI/beta-blocker did not differ between races.
Comparison of the clinical outcome between the races is shown in Fig. 1 . Indians and Malays were more likely than the Chinese to reach the composite end-point (40.9% and 36.9% vs 26.7%, p = 0.01). While Indians and Malays had higher CHF readmission rates compared to the Chinese (29.6% and 21.6% vs 14.3%, p b 0.01), a trend towards a higher all-cause mortality was seen among Malays, compared to Indians or Chinese (27.0% vs 14.3% vs 18.6%, p = 0.12).
Univariate and multivariate predictors of the composite end-point are shown in Table 1 . Malay race was an independent predictor of the composite end-point (OR = 1.65, 95% CI = 1.04-2.63, p = 0.034), as were age (p = 0.011), DM (p = 0.002), ischemic cardiomyopathy (p = 0.023), beta-blocker use (p = 0.001), and NYHA class (p = 0.007 and 0.001). Although Indian race was a strong predictor of clinical outcome on univariate analysis, it was not independently associated with the composite end-point.
Discussion
Our findings confirm the results of a previous study evaluating 10-year trends in CHF mortality and admissions in Singapore, which showed 35% higher CHF admission rates among Malays and Indians, and 3.5 times higher CHF mortality in Malays, compared to Chinese and Indians [4] .
Our results demonstrate higher composite end-point rates among Indians and Malays compared to Chinese, due to higher CHF readmission rates in Indians and higher CHF readmission and mortality rates in Malays.
Importantly, DM, peripheral vascular disease, and hyperlipidemia were more prevalent among Indians, compared to Chinese or Malays, consistent with a previous epidemiologic study [5] . A trend towards greater prevalence of ischemic cardiomyopathy among Indians was also seen.
Although Indian race was strongly associated with the composite end-point on univariate analysis, it was not an independent predictor of clinical outcome. However, both DM and ischemic cardiomyopathy were independent predictors of the composite end-point, suggesting that the greater burden of DM and atherosclerotic vascular disease among Indians may be the primary determinant of their poorer clinical outcome.
The adverse impact of DM in patients with CHF, especially those with ischemic cardiomyopathy is well established and has previously been reported [6] .
The poorer prognosis among Malays compared to Chinese could not be explained on the basis of comorbidities alone. Although DM was more prevalent in Malays compared to Chinese, Malay race was an independent predictor of the composite end-point, suggesting that other race-specific factors independent of comorbidities could be contributory. Possible explanations include treatment non-compliance, use of naturopathic supplements that could worsen CHF, or racial differences in rates of disease progression or response to drug therapy, although these causes were not studied systematically and their role is speculative. Income ≤ $1K = monthly income ≤ SGD$1000; CVA = cerebrovascular accident; PVD = peripheral vascular disease; CRF = chronic renal failure; COLD = chronic obstructive lung disease; ACEI/ARB = angiotensin converting enzyme inhibitors/angiotensin receptor blockers; CABG = coronary bypass surgery; PCI = percutaneous coronary intervention; EF = left ventricular ejection fraction; NYHA = New York Heart Association; 6MWT = six minute walk test distance in metres OR = odds ratio; 95% CI = 95% confidence intervals.
A previous study in a UK CHF population [7] demonstrated that ethnic differences in socio-cultural beliefs and knowledge levels, especially when comparing Indo-Asians and Afro-Caribbeans with Caucasians may result in differing perceptions of CHF and treatment, potentially affecting treatment compliance and hence outcome.
Conclusions
In spite of recent advances in CHF treatment, a racial disparity in outcomes is evident in the multiracial population of Singapore, with Indians and Malays having a worse prognosis compared to the Chinese, due to higher CHF readmission rates among Indians and higher CHF readmission and mortality rates among Malays. While the greater burden of DM and atherosclerotic vascular disease in Indians could explain their worse outcome, the reasons for the poorer prognosis in Malays are unclear, reinforcing the need for further research in this area.
